|
Nina is a Partner in the Life Sciences Group of InterWest Partners, focusing primarily on investments in the biopharmaceutical area. She currently represents InterWest on the boards of Nereus Pharmaceuticals and NovaCardia, Inc. Ms. Kjellson is an observer on the boards of AkaRx, Inc., Devax, Inc., Kanisa Pharmaceuticals, MacuSight, Inc., and ReVision Optics. Ms. Kjellson also played a primary role in InterWest's investment in Aspreva Pharmaceuticals (NASDAQ:ASPV). Prior to joining InterWest, Ms. Kjellson was an Investment Manager at Bay City Capital, a life sciences merchant bank, and a Research Associate at Oracle Partners, a health care focused hedge fund. She began her career conducting health policy and survey research with the Kaiser Family Foundation. Ms. Kjellson holds a degree in Human Biology from Stanford University. | 